Global Molecular Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 20.10 Billion |
 Market Size (Forecast Year) |
USD 54.76 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球分子诊断市场，产品（试剂和试剂盒、仪器、服务和软件）、技术（质谱 (MS)、毛细管电泳、下一代测序 (NGS)、芯片和微阵列、基于聚合酶链反应 (PCR) 的方法、细胞遗传学、原位杂交 (ISH 或 FISH)、分子成像等）、应用（肿瘤学、药物基因组学、微生物学、产前检查、组织分型、血液筛查、心血管疾病、神经系统疾病、传染病等）、最终用户（医院、临床实验室、学术界）– 行业趋势和预测到 2030 年。
分子诊断市场分析和规模
全球传染病和癌症发病率的不断上升增加了分子诊断的应用。主要市场参与者现在主要关注分子诊断的技术进步。此外，在 COVID-19 期间，诊断行业也出现了大幅增长，人们竞相开发用于检测冠状病毒的新型快速诊断试剂盒。2021 年，赛默飞世尔科技报告称，由于诊断部门实现了 150% 的增长，其收入增长了 59%。
Data Bridge Market Research 分析，分子诊断市场规模将从 2022 年的 201 亿美元增至 2030 年的 547.6 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 13.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
分子诊断市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（试剂和试剂盒、仪器、服务和软件）、技术（质谱（MS）、毛细管电泳、下一代测序（NGS）、芯片和微阵列、基于聚合酶链反应（PCR）的方法、细胞遗传学、原位杂交（ISH 或 FISH）、分子成像、其他）、应用（肿瘤学、药物基因组学、微生物学、产前检查、组织分型、血液筛查、心血管疾病、神经系统疾病、传染病、其他）、最终用户（医院、临床实验室、学术机构） |
|
覆盖国家 |
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
F. Hoffmann-La Roche Ltd (Switzerland), Hologic, Inc., (U.S.), bioMérieux (France), Abbott (U.S.), QIAGEN (Netherlands), Thermo Fisher Scientific (U.S.), Siemens (Germany), Danaher (U.S.), Myriad Genetics Inc. (U.S.), Illumina Inc. (U.S.), Agilent Technologies Inc. (U.S.), BD (U.S.), DiaSorin S.p.A (Italy), Grifols S.A. (Spain), Quidel Corporation (U.S.), Genetic Signatures (Australia), MDxHealth, Inc. (U.S.), Exact Sciences Corporation (U.S.), Biocartis (Belgium), TBG Diagnostics Limited (Australia), GenMark Diagnostics Inc. (U.S.), Luminex Corporation (U.S.), HTG Molecular Diagnostics Inc. (U.S.), Vela Diagnostics (Singapore), Amoy Diagnostics Co., Ltd. (China), Molbio Diagnostics Pvt. Ltd. (India) geneOmbio (India) |
|
Market Opportunities |
|
Market Definition
Molecular diagnosis can detect the diseases such as hereditary diseases, infectious diseases, neurological diseases, cardiovascular diseases, and others by examining molecules such as DNA, RNA, and protein in a tissue or a fluid. Numerous methods, such as mass spectrometry, PCR, next-generation sequencing, in situ hybridization, molecular imaging, and others, are used to diagnose several diseases. Molecular diagnostics uses strong technologies such as DNA sequence analysis, gene expression profiling, and biomarker identification to identify disorders correctly.
Global Molecular Diagnostics Market Dynamics
Drivers
- Increasing Elderly Population
The increasing geriatric population worldwide is surging the risk of getting several diseases, such as cardiovascular diseases, cancer, obesity, neurological disorders, and diabetes. As per the UN report, in 2020, there were around 727 million people aged 65 years and above worldwide. In addition to this, the number of individuals aged 80 years and above is anticipated to double by 2050. The geriatric population is more likely to suffer from multiple diseases due to multimorbidity, decreased immune function, and aging-related physiological changes. Thus, this factor boosts market growth.
- High Usage of PCR
PCR is highly used in CROs, research institutes, and hospitals, enhancing the market growth rate. The growing use of high-throughput PCR technology to detect infectious and genetic diseases is anticipated to surge market growth. For instance, Seegene announced the launch of its upcoming Allplex SARS-CoV-2 Fast PCR Assay in 2022. The test has a turnaround time of 60 minutes and thus is appropriate for mass testing. Thus, this factor boosts market growth.
Opportunities
- Increasing Demand for Molecular Diagnostics in Point-of-Care Setting
In recent years, molecular diagnostic platforms have been widely used in PoC settings. Numerous companies are designing molecular diagnostic platforms and assays for POC or near-patient testing. In addition to this, the increasing development of new assays that provide quick PoC results is estimated to enhance market growth. For instance, Abbott launched a molecular point of care test, the ID NOW COVID-19 test, to diagnose COVID-19 in less than 5 minutes in 2020. Thus, this factor boosts market growth.
- Increasing Prevalence of HIV
The increasing incidence of infectious diseases is anticipated to boost market growth over the forecast period. The growing occurrence of STIs, such as HIV and HPV, is anticipated to enhance the market growth as all these diseases demand a high rate of molecular tests. As per the WHO records, the prevalence of HIV was approximately 37.7 million and 1.5 million, respectively, in 2020. Additionally, people who have HIV are highly vulnerable to other infections, such as tuberculosis. All these infectious diseases demand multiple molecular tests, which will further help in faster treatment processes. Thus, this factor boosts market growth.
Restraints/Challenges
- Increasing Regulatory Approvals
The regulatory framework for approval is the main limiting factor in the market's growth. Many times, inaccurate results may be attained because of some fault in the diagnostic kits or an untrained person performing the test. Thus, strict regulation has been related to the approval process. Thus, this factor is restricting the market growth.
This molecular diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the molecular diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, Roche Diagnostics India launched the Cobas 8800 and the Cobas 6800 at the National Institute of Cholera and Enteric Diseases, Kolkata, to help the SARS CoV-2 diagnostic testing. The Roche Cobas 6800/8800 systems deliver test findings in a time of three and a half hours and allow greater operational efficiency, flexibility, and the quickest time-to-results.
- In 2021, Roche completed the acquisition of TIB Molbiol Group. TIB Molbiol Group has about 45 CE-IVD-approved assays for diagnosing inherited genetic testing, infectious diseases, transplant medicine, and hematology testing.
Global Molecular Diagnostics Market Scope
The molecular diagnostics market is segmented on the basis of products, technology, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Reagents and Kits
- Instruments
- Services and Software
Technology
- Mass Spectrometry (MS)
- Capillary Electrophoresis
- Next Generation Sequencing (NGS)
- Chips and Microarray
- Polymerase Chain Reaction (PCR)-Based Methods
- Cytogenetics
- In Situ Hybridization (ISH or FISH)
- Molecular Imaging
- Others
Application
- Oncology
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancers
- Pharmacogenomics
- Microbiology
- Prenatal Tests
- Tissue Typing
- Blood Screening
- Cardiovascular Diseases
- Neurological Diseases
- Infectious Diseases
- COVID-19
- Hepatitis
- HIV
- CT/NG
- HAI
- HPV
- Tuberculosis
- Influenza
- Others
- Others
End User
- Hospital
- Clinical Laboratories
- Academics
Molecular Diagnostics Market Regional Analysis/Insights
The molecular diagnostics market is analyzed and market size insights and trends are provided by products, technology, application and end user as referenced above.
The countries covered in the molecular diagnostics market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the molecular diagnostics market because of the increased per capita healthcare expenditure and increasing demand for better healthcare facilities. Also, a high standard of living and consumer awareness about early diagnosis, and the well-established healthcare system are major factors for the market growth.
Asia-Pacific is expected to witness significant growth due to the high elderly population, growing incidence of cancer and varied infectious disease in countries such as China and India, and the advanced healthcare infrastructure within the region.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
分子诊断市场还为您提供每个国家/地区资本设备医疗支出增长、分子诊断市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对分子诊断市场的影响的详细市场分析。数据涵盖 2011-2021 年的历史时期。
竞争格局和分子诊断市场份额分析
分子诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对分子诊断市场的关注有关。
分子诊断市场的一些主要参与者包括：
- F. Hoffmann-La Roche Ltd（瑞士）
- Hologic, Inc.（美国）
- 生物梅里埃（法国）
- 雅培（美国）
- QIAGEN（荷兰）
- 赛默飞世尔科技（美国）
- 西门子（德国）
- 丹纳赫（美国）
- Myriad Genetics Inc.（美国）
- Illumina Inc.（美国）
- 安捷伦科技公司（美国）
- BD（美国）、DiaSorin SpA（意大利）
- Grifols SA（西班牙）
- Quidel 公司（美国）
- 基因特征（澳大利亚）
- MDxHealth, Inc.（美国）
- Exact Sciences Corporation（美国）
- Biocartis（比利时）
- TBG Diagnostics Limited（澳大利亚）
- GenMark Diagnostics Inc.（美国）
- Luminex 公司（美国）
- HTG Molecular Diagnostics Inc.（美国）
- Vela Diagnostics（新加坡）
- 厦门诊断设备股份有限公司 (中国)
- Molbio Diagnostics Pvt. Ltd.（印度）
- geneOmbio（印度）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
